[go: up one dir, main page]

EE9900384A - Surmaefektori domeeniga CASH (kaspaasi homoloog) molekulid, FAS retseptorite funktsiooni modulaatorid - Google Patents

Surmaefektori domeeniga CASH (kaspaasi homoloog) molekulid, FAS retseptorite funktsiooni modulaatorid

Info

Publication number
EE9900384A
EE9900384A EEP199900384A EEP9900384A EE9900384A EE 9900384 A EE9900384 A EE 9900384A EE P199900384 A EEP199900384 A EE P199900384A EE P9900384 A EEP9900384 A EE P9900384A EE 9900384 A EE9900384 A EE 9900384A
Authority
EE
Estonia
Prior art keywords
cash
modulators
molecules
receptor function
fas receptor
Prior art date
Application number
EEP199900384A
Other languages
English (en)
Inventor
Wallach David
Goltsev Yura
Kovalenko Andrei
Varfolomeev Eugene
Brodianski Vadim
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12036797A external-priority patent/IL120367A0/xx
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE9900384A publication Critical patent/EE9900384A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
EEP199900384A 1997-03-03 1998-02-26 Surmaefektori domeeniga CASH (kaspaasi homoloog) molekulid, FAS retseptorite funktsiooni modulaatorid EE9900384A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12036797A IL120367A0 (en) 1997-03-03 1997-03-03 Modulators of the function of FAS receptors and other proteins
IL12075997A IL120759A0 (en) 1997-03-03 1997-05-01 Modulators of the function of fas receptors and other proteins
PCT/IL1998/000098 WO1998039435A1 (en) 1997-03-03 1998-02-26 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors

Publications (1)

Publication Number Publication Date
EE9900384A true EE9900384A (et) 2000-04-17

Family

ID=26323378

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900384A EE9900384A (et) 1997-03-03 1998-02-26 Surmaefektori domeeniga CASH (kaspaasi homoloog) molekulid, FAS retseptorite funktsiooni modulaatorid

Country Status (18)

Country Link
US (1) US7419804B2 (et)
EP (1) EP0977842A1 (et)
JP (1) JP2002500508A (et)
KR (1) KR100544776B1 (et)
CN (1) CN1148446C (et)
AU (1) AU740223B2 (et)
BG (1) BG64799B1 (et)
BR (1) BR9808173A (et)
CA (1) CA2281484A1 (et)
EA (1) EA003269B1 (et)
EE (1) EE9900384A (et)
HU (1) HUP0000913A3 (et)
IL (3) IL120759A0 (et)
NO (1) NO994250L (et)
NZ (1) NZ337143A (et)
PL (1) PL193394B1 (et)
SK (1) SK117599A3 (et)
WO (1) WO1998039435A1 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19713393C2 (de) * 1997-04-01 2002-12-05 Apotech Res & Dev Ltd Flip-Gen und Flip-Protein
DE19713434C1 (de) * 1997-04-01 1998-09-24 Deutsches Krebsforsch Protein zur Inhibierung von Apoptose
WO2000003023A1 (en) * 1998-07-08 2000-01-20 Merck Frosst Canada & Co. Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex
US7052834B1 (en) 1998-12-31 2006-05-30 St. Jude Children's Research Hospital Tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein
WO2000039347A1 (en) * 1998-12-31 2000-07-06 St. Jude Children's Research Hospital A tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein
US20020174450A1 (en) * 2000-12-11 2002-11-21 Allen Keith D. Transgenic mice containing cash gene disruptions
CN110988354A (zh) * 2019-11-15 2020-04-10 同济大学 一种分泌蛋白Caspase1在早期心梗诊断试剂中的应用
CN116426678B (zh) * 2023-03-27 2024-03-22 中国热带农业科学院三亚研究院 与番木瓜果肉果糖含量相关的snp分子标记及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
EP0841399A3 (en) * 1996-11-12 1998-07-08 Smithkline Beecham Corporation Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
CA2278349A1 (en) 1997-01-21 1998-07-23 Human Genome Sciences, Inc. I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis
US6242569B1 (en) 1997-02-05 2001-06-05 Tularik, Inc. Regulators of apoptosis
DE19713393C2 (de) * 1997-04-01 2002-12-05 Apotech Res & Dev Ltd Flip-Gen und Flip-Protein
US6207458B1 (en) * 1998-05-07 2001-03-27 University Of Washigton/Stowers Insitute For Medical Research Proteins capable of regulating NF-κB JNK and apoptosis pathways and methods of using the same

Also Published As

Publication number Publication date
CA2281484A1 (en) 1998-09-11
SK117599A3 (en) 2000-05-16
HUP0000913A3 (en) 2001-11-28
JP2002500508A (ja) 2002-01-08
EA003269B1 (ru) 2003-02-27
US20060216788A1 (en) 2006-09-28
IL131247A (en) 2007-08-19
KR20000075721A (ko) 2000-12-26
BG64799B1 (bg) 2006-04-28
PL335448A1 (en) 2000-04-25
KR100544776B1 (ko) 2006-01-23
NO994250D0 (no) 1999-09-02
AU740223B2 (en) 2001-11-01
IL131247A0 (en) 2001-01-28
PL193394B1 (pl) 2007-02-28
HK1024508A1 (en) 2000-10-13
EA199900794A1 (ru) 2000-04-24
AU6112698A (en) 1998-09-22
BR9808173A (pt) 2000-05-16
HUP0000913A2 (hu) 2000-06-28
US7419804B2 (en) 2008-09-02
NZ337143A (en) 2001-12-21
IL120759A0 (en) 1997-09-30
CN1249780A (zh) 2000-04-05
EP0977842A1 (en) 2000-02-09
CN1148446C (zh) 2004-05-05
WO1998039435A1 (en) 1998-09-11
NO994250L (no) 1999-11-02
BG103693A (en) 2000-05-31

Similar Documents

Publication Publication Date Title
DE69709255D1 (de) Polarisationsunabhängiger elektrooptischer modulator
DE59801169D1 (de) Elektrooptische koppelbaugruppe
DE69831507D1 (de) Simulationssystem mit auflösung von bedingungen
ATE362629T1 (de) Transaktionssystem
NO993736D0 (no) Termisk bildedannende forretningsformular med omrÕde som er maskert eller gjort ufölsomt
DE69603141D1 (de) Dispersionskompensation
DE69826349D1 (de) Flüssigkristallanzeige
DE69829733D1 (de) Sicherheitssystem
FI972457L (fi) FAS/APO1-reseptorien toiminnan modulaattorit
DE69815674D1 (de) Optisches system,bestehend aus einer bilddarstellung und einer augenanalyse
DE69801042D1 (de) Sicherheitssystem
EE9900384A (et) Surmaefektori domeeniga CASH (kaspaasi homoloog) molekulid, FAS retseptorite funktsiooni modulaatorid
NO960227D0 (no) Sikkerhetssystem
FI960377A7 (fi) Lämpöstabiileja polarisaattoreita
DE69611758D1 (de) N-1-carbocylalkyl derivate von lsd
ID20597A (id) Zat warna terdispersi
DE69916461D1 (de) Sicherheitssystem
DE69800880D1 (de) Akustooptische Modulatoren mit planaren Wellenleitern
ATA192697A (de) Schutzbeschlag
EP1048973A4 (en) ELECTROCHROMIC ELEMENT
DE69905627D1 (de) Anzeige der Verteilung von Hilfsdaten
ATE238786T1 (de) Anti-first-pass-effect-substanzen
ITTO960079A0 (it) Graffa di fissagio e sua utilizzazione.
ES1031526Y (es) Cabina de seguridad para entidades bancarias y similares.
FI974496A0 (fi) Foerfarande och anordning foer modulering av en signal